Box plots for subsets of male originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”

Changes in SHR body weight, hemodynamics and cardiac function before and after training. by Zhaowen Tan (12283502)

Subjects:

Properties of differential lipids that have increased and decreased abundance in the BmNPV-infected group of head samples at 96 hpi. by Min Feng (141118)

Change of proportions between phases and statistical test results (corresponding to Figs 2–4). by Lan Li (73597)

Subjects:

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

Change in health utilization measures by group and difference in magnitude of change between groups. by Emily Lyles (3174990)

Subjects:

Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

“…Scatter plots of the RNASeq DESeq results, P-value vs. Fold Change for each sample day, arranged chronologically. …”

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically si... by Oswaldo Maillard (20660661)

Exosomal miR-122 inhibition increases hepatic stellate cell proliferation and fibrosis marker expression. by Young Chang (3666829)

Subjects:

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Growth rates and cell volumes. by Kathryn J. Coyne (11614403)

Subjects:

Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2... by Ingvild Hersoug Nedberg (11384048)

Subjects:

Illustration summarizing changes in measured parameters. by Kathryn J. Coyne (11614403)

Subjects:

Mean liver function protein level changes over time. by Carmen Leser (3809554)

Subjects:

PAS staining images of pathological changes in renal tissues among 4 groups (×400). by Jian-feng Li (8667645)

Subjects:

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…The orange color indicates increase in levels and the blue color represent decrease in levels. (A) MMS status, yes vs. no (B) change in (Δ) QMG (> 40% vs. < 0%) (C) change in (Δ) MG-ADL (> 40% vs. < 0%), (D) Responder versus Non-Responder. …”

Alterations in CBC parameters in albino rats of both genders after 60 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects:

Alterations in CBC parameters in albino rats of both genders after 30 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects:

Alterations in CBC parameters in albino rats of both genders after 90 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

Subjects: